# FDA 483 - Biocon Biologics Limited - August 26, 2022

Source: https://www.globalkeysolutions.net/records/483/biocon-biologics-limited/6d696c01-1fee-4b41-9f1e-ae5c564a08fa

> FDA 483 for Biocon Biologics Limited on August 26, 2022. Product: Drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Biocon Biologics Limited
- Inspection Date: 2022-08-26
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [483 - 2019-02-15](https://www.globalkeysolutions.net/records/483/biocon-biologics-limited/3858f9b9-9837-4adb-9001-eeb4c7a62761)
- [483 - 2017-04-07](https://www.globalkeysolutions.net/records/483/biocon-biologics-limited/9003f4e1-97b6-4bc9-89a4-c3d018f10822)
- [483 - 2018-05-01](https://www.globalkeysolutions.net/records/483/biocon-biologics-limited/6fa7e974-b5c4-450b-bb8f-8eb76ae4b514)
- [483 - 2017-06-03](https://www.globalkeysolutions.net/records/483/biocon-biologics-limited/d469f0a6-221d-4b96-a912-d98125df7f1b)
- [483 - 2024-07-26](https://www.globalkeysolutions.net/records/483/biocon-biologics-limited/05a654d1-f83f-49b1-80a9-56f70dca615f)

## Related Officers

- [Zhong Li](https://www.globalkeysolutions.net/people/zhong-li/18545b20-7fa5-4850-9dd4-cffb40c41f8d)
- [Aden Kazi](https://www.globalkeysolutions.net/people/aden-kazi/23519e27-0e8d-4155-b25b-20925ca413ac)
- [Ital M. Semmel](https://www.globalkeysolutions.net/people/ital-m-semmel/43921770-66b0-48f8-968d-7e7803e98ed5)

Company: https://www.globalkeysolutions.net/companies/biocon-biologics-limited/7eb84509-8dc4-4765-9a0e-d2f65781328d

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c